It is already approved to prevent RSV-LRTD in individuals aged 60 and older in 61 countries and regions, including the US, ...

In contrast to current standard of care in patients with CKD which requires injections, GSK noted that Duvroq offers convenience with oral administration and flexibility with once-daily dosing ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

Regulators in the EU, China, and Japan have started reviews of GSK's depemokimab, aiming to become the first drug for severe asthma that can be given just twice a year. The EMA and counterparts in ...